There is an increase in NGF levels in human pain conditions that are characterized by inflammation, such as arthritis (70, 71), and NGF applied exogenously to the human skin or muscle produces hyperalgesia or allodynia (72, 73). This evidence concerns the gene NGF and arthritic joint disease.